← Back to Search

Behavioral Intervention

Culturally Tailored Recovery Programs for Substance Abuse (IMANI U Trial)

N/A

Recruiting

Led By Chyrell Bellamy, Ph.D.

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must meet criteria for a DSM-5 Alcohol Use Disorder and/or Opioid Use Disorder and are currently using alcohol and/or other opioids within the last 30 days

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-month

Awards & highlights

IMANI U Trial Summary

This trial is testing ways to get more people of color into medication assisted treatment programs.

Who is the study for?

This trial is for Black or Latinx individuals who want to reduce substance use and have been diagnosed with Alcohol Use Disorder or Opioid Use Disorder, using substances within the last month. They must be interested in treatment and agree to participate by signing a consent form.Check my eligibility

What is being tested?

The study is testing culturally tailored recovery programs: IMANI, Telehealth MAT (Medication Assisted Treatment), and traditional MAT with extra support for accessing services. It aims to improve access and engagement in treatment among communities of color.See study design

What are the potential side effects?

While specific side effects are not detailed here, typical side effects from Medication Assisted Treatments can include nausea, headaches, dizziness, fatigue, mood swings, and potential withdrawal symptoms depending on the medication used.

IMANI U Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with an alcohol or opioid use disorder and have used these substances in the last 30 days.

IMANI U Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall attendance of program

Overall treatment adherence

Secondary outcome measures

Change in substance abuse

IMANI U Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: IMANI BREAKTROUGH + church-based telehealth MAT option (IMANI + CTM)Experimental Treatment2 Interventions

Participants will participate in the 24-week Imani weekly group. During weeks 1-4 participants will received education on MAT. Those participants randomized will receive the IMANI weekly group as well as a church based telehealth Medication Assisted Treatment option. The church based telehealth MAT will consist of participants assigned to receive MAT from addiction treatment providers via telehealth. Telehealth sessions will be provided in the church.

Group II: IMANI BREAKTHROUGH + Traditional MAT plus Referral and LinkageExperimental Treatment2 Interventions

Participants will participate in the 24-week Imani weekly group. During weeks 1-4 participants will received education on MAT. Those participants randomized will receive the IMANI weekly group as well as Traditional MAT services with Referral and Linkage to services. Participants in this arm will be provided a list of referrals and links to community MAT providers. They will choose their providers.

Group III: IMANI BREAKTHROUGHActive Control1 Intervention

Participants will participate in 24-week IMANI weekly groups

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,848 Previous Clinical Trials

2,737,293 Total Patients Enrolled

17 Trials studying Substance Abuse

3,402 Patients Enrolled for Substance Abuse

National Institutes of Health (NIH)NIH

2,697 Previous Clinical Trials

6,952,289 Total Patients Enrolled

5 Trials studying Substance Abuse

1,346 Patients Enrolled for Substance Abuse

Chyrell Bellamy, Ph.D.Principal InvestigatorYale University

1 Previous Clinical Trials

204 Total Patients Enrolled

Media Library

IMANI (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05260047 — N/A

Substance Abuse Research Study Groups: IMANI BREAKTHROUGH + Traditional MAT plus Referral and Linkage, IMANI BREAKTHROUGH, IMANI BREAKTROUGH + church-based telehealth MAT option (IMANI + CTM)

Substance Abuse Clinical Trial 2023: IMANI Highlights & Side Effects. Trial Name: NCT05260047 — N/A

IMANI (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05260047 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional participants being taken into this investigation?

"The clinical trial is presently recruiting, according to information found on clinicaltrials.gov. It was first posted on July 11th 2022 and the last update occurred August 10th of that same year."

Answered by AI

What is the aggregate number of people involved in this experiment?

"Affirmative. According to clinicaltrials.gov, the medical trial commenced on July 11th 2022 and has had a recent update as of August 10th 2022. This requires 525 individuals across 7 sites for enrolment in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

2022. "Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05260047.

All > Substance Abuse